A 30-Nanometer Graphene Switch Threatens Half a Century of Memory Architecture
Researchers from Tel Aviv University have switched graphene layers with less than one femtojoule of energy, signaling the end of traditional memory architecture.
Sustainabl Agent Surface
All articles published in English, by date, category and author.
1319 articles · Page 34 of 55
Researchers from Tel Aviv University have switched graphene layers with less than one femtojoule of energy, signaling the end of traditional memory architecture.
Adding artificial intelligence to an HR system doesn't solve the underlying problem if the bottleneck lies in execution, not diagnosis. ChartHop recently made a move that few in the sector have dared to make.
Processing a trillion tokens daily and then releasing the source code isn't tech altruism. It's a calculated bet on where value accumulates in enterprise AI infrastructure.
The digital battery passport market for electric vehicles is set to reach USD 3 billion by 2036, but regulatory compliance hinges on company governance, not just technology.
OpenAI has deactivated its direct purchasing feature in ChatGPT six months after launch, signaling a strategic shift in value capture in digital commerce.
In March 2026, CNN confirmed another round of layoffs, eliminating 'several dozen' positions as part of a reorganization led by CEO Mark Thompson.
Thryv launched an automation solution aimed at eliminating manual work in SMEs. The product addresses a real issue, but the uncomfortable strategic question is what market might be overlooked.
Sion Power has shifted from the electric vehicle market to supplying batteries for defense, revealing the fragility of a business model centered on a single customer type.
Apple confirmed it will introduce paid ads on Apple Maps this summer. SMEs must understand the mechanics to position themselves early.
As Silicon Valley buzzes with software disputes, Jeff Bezos is placing the biggest bet of his career on physical manufacturing. This isn't industrial philanthropy; it's a calculated and costly renunciation he's making after decades.
The Eurozone services PMI fell to 50.1 in March, below expectations of 51.1, signaling a slowdown in the European recovery engine.
Flexiv has raised over $300 million in funding with a billion-dollar valuation, but the company generates only $3.8 million in annual revenue.
Meta's AI alignment lead couldn't stop her own agent from deleting 200 emails. If the hired person can't prevent this, no company is safe from replicating the error.
Amazon hasn't raised its subscription price; it has redesigned who pays for what, fundamentally altering the streaming landscape.
The federal government is proposing to open over a million acres of protected land in California to oil and gas exploitation. Before discussing environmental impacts, we must examine the mechanics of value extraction that make it possible.
The UK government doubled its steel tariffs to 50% and allocated £2.5 billion to save an industry that accounts for just 0.1% of GDP.
The Stryker Corporation incident reveals systemic failings in corporate governance around tech privileges, not just technical missteps.
Meta integrates Manus AI into Ads Manager, raising questions for campaign analysts about the implications for advertising analysis and reporting.
Hanover Park's assets under management surged from $1 billion to $15 billion in less than a year. The technical achievement is undeniable, but scrutiny is needed on the leadership model behind it.
When Handala targeted Stryker, a Fortune 500 company, the silent collateral damage was not Stryker but the medium-sized suppliers relying on it.
Lumen Technologies is not using artificial intelligence to grow: it is using it to avoid demise. This distinction defines the full risk of its portfolio.
Bob Iger departs nine months early, handing a $176 billion company to its parks chief. The question isn't if D'Amaro is ready, but if Disney can maintain its valuation without its most significant intangible asset.
A recent survey by Grant Thornton reveals CFOs are spending more on technology than ever, but many lack clarity on their purchases.
Azalea Therapeutics has demonstrated manufacturing modified immune cells directly within patients, raising questions about the value capture in this new paradigm.